Your dog was diagnosed with Renal Carcinoma. Uncommon (~1% of canine tumours). Renal cell carcinoma is the most common primary renal malignancy. Often unilateral. May be incidental finding on imaging. German Shepherds at hereditary risk (BHD gene mutation — renal cystadenocarcinoma). Compare 2 treatment options for dogs including Nephrectomy, Palliative / Supportive Care — with survival times, costs, and what to expect during treatment.
Pet Cancer Options — Renal Carcinoma
Canine Oncology Treatment Guide
Renal Carcinoma
Epithelial
About This Cancer
Renal cell carcinoma is a cancer arising from the epithelial cells of the kidney tubules — the microscopic structures responsible for filtering blood and producing urine. It is the most common primary malignant kidney tumour in dogs, though it remains uncommon overall. The tumour is usually unilateral (affecting one kidney), and surgical removal of the affected kidney (nephrectomy) can be curative if the cancer has not spread. Many cases are found incidentally during abdominal imaging for other reasons. German Shepherd Dogs have a hereditary predisposition through a specific gene mutation (in the BHD/folliculin gene) that causes a distinct form called renal cystadenocarcinoma. Prognosis depends on whether the cancer has spread at the time of surgery and on the tumour's microscopic features, particularly how actively the cells are dividing.
Modified staging for canine renal tumours
Staged by local extent, vascular invasion, and distant metastasis
Prognostic Factors(2)
Minimum Workup(7 steps)
Median Survival Time Comparison
How long the average patient survives with each treatment
Each treatment is rated by how much published research supports its use. Solid bars indicate stronger evidence; dashed bars mean less certainty.
Please note: All treatment data is sourced from published peer-reviewed literature. Survival times and cost figures are approximate guides. Your pet's individual factors — including tumour grade, stage, and overall health — will influence outcomes and should guide all treatment decisions. The strength-of-evidence rating reflects how much research exists, not how strongly a treatment is recommended. This tool is designed to help you have informed conversations with your veterinary oncologist, not to replace them. Costs shown are US referral centre estimates and may vary significantly by region.